Medical Properties Trust vs Sabra Health Care REIT
MPT and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MPT and SBRA compare
Sabra Health Care REIT is the larger company, worth 5.2 times as much as Medical Properties Trust ($5.2B against $997M).
Sabra Health Care REIT grew revenue faster over the last twelve months (23.4% versus 10.6% for Medical Properties Trust).
Sabra Health Care REIT keeps more of each dollar of sales as profit, with a net margin of 7.8% compared with −3.0% at Medical Properties Trust.
Both pay dividends: Medical Properties Trust yields 21.6% and Sabra Health Care REIT 7.3%.
Medical Properties Trust scores higher on the StockData Score (9 against 6 for Sabra Health Care REIT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MPT | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $997M | $5.2B |
| Share price | $1.67 | $20.44 |
| Change, 1 year | −66.5% | 8.3% |
| Change, 5 years | −92.3% | 43.7% |
| Beta (5Y) | 1.22 | 0.46 |
| Employees | 121 | 58 |
| StockData Score | ||
| Total score | 9 (better) | 6 |
| Valuation score | 4 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | – | 73.0× |
| P/S | 1.0× (better) | 5.7× |
| P/B | 0.2× (better) | 1.8× |
| EV/EBITDA | 0.8× (better) | 12.7× |
| Fair value | $7.87 | $12.97 |
| Margin of safety | 78.8% (better) | −57.6% |
| Growth | ||
| Revenue growth (TTM) | 10.6% | 23.4% (better) |
| Revenue growth, 5Y average | −4.9% | 5.3% (better) |
| Net income growth (TTM) | – | −59.2% |
| EPS growth (TTM) | – | −61.1% |
| EPS growth, 5Y average | – | −0.91% |
| Profitability | ||
| Net margin | −3.0% | 7.8% (better) |
| Return on equity | −0.65% | 2.5% (better) |
| Financial health | ||
| Altman Z-score | −0.27 | 1.38 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 21.6% (better) | 7.3% |
| Payout ratio | – | 423% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −21.4% | −2.3% (better) |
| Shareholder yield | 21.6% (better) | 7.3% |
| Ownership | ||
| Held by institutions | 61.1% | 102% |
| Held by insiders | 2.2% | 1.9% |
| Insider net buying, 12 months | −$455 (better) | −$4.7M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 25.5% | 7.1% |
Go deeper
- MPT stock overview
- MPT income statement
- MPT valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.